Flow Cytometry is a technology in biotechnology based on impedance or laser and is employed in cell sorting, cell counting, protein engineering and biomarker detection. This is done by suspending the cells in a fluid stream and then allowing them to pass through an electronic apparatus for detection purposes. It is used in the diagnosis of several health disorders, especially blood cancer and is also applied in basic research, clinical trials and various clinical practices. Microbiology domain has benefited with the introduction of flow cytometry. It is used in the analysis and measurement of several physical characteristics of chromosomes, cells etc., surrounded by suspensions heterogenic in nature. The device used to carry out flow cytometry is called flow cytometer. This device performs multi parameter analysis of the chemical as well as physical characteristics of about thousand particles every second simultaneously. Flow cytometer includes main four elements, such as lasers, fluidic systems, external computer systems and optics. Additionally, in order to collect cells, a sorting device is also used, typically referred to as cell sorter.
According to the research, commercial organizations are a large scale users of flow cytometry as compared to academic institutions. The commercial organizations segment by end user category is anticipated to grow at the highest CAGR of 7.5% during the period of forecast 2017-2022. This segment reflected a higher market share in 2017 and is likely to retain its status quo throughout the period of forecast, and is estimated to project a higher valuation by end of 2022. Thus the commercial organization segment is likely to lead the global market by end user during the 2017-2022 period.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5263
The in-depth market research report on global market for flow cytometry covers a weighted competitive analysis wherein it covers various aspects of key players involved in this market. Key players such as Danaher Corporation, Becton Dickinson and Company, Sysmex Corporation, Agilent Technologies, Inc., Merck & Co Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Luminex Corporation, General Electric Company and Miltenyi Biotec GmbH are outlined in this research study.